MASH finally has a drug worth watching and UC San Diego's…

MASH finally has a drug worth watching and UC San Diego's ION224 is it Metabolic-associated steatohepatitis affects tens of millions globally and has almost no approved treatments. A new experimental compound just changed that calculation. MASH, previously called NASH, is the aggressive form of fatty liver disease driven by metabolic dysfunction. It can silently progress to cirrhosis and liver failure, and until recently, clinicians h